Browsing by Yonsei Author : Kim, Seung Up

eperson profile image
Name:
Kim, Seung Up [김승업]
orcid http://orcid.org/0000-0002-9658-8050
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (54933821200)

Keyword Cloud

Researcher Network

Showing results 51 to 100 of 334

This table browses all dspace content
Issue DateTitleJournal Title
2021Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2021Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinomaALIMENTARY PHARMACOLOGY & THERAPEUTICS
2021Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis BHEPATOLOGY RESEARCH
2021Authors' response: Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infectionJOURNAL OF VIRAL HEPATITIS
2021Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization Journal of Liver Cancer(대한간암학회지)
2021A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer Journal of Liver Cancer(대한간암학회지)
2021Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular CarcinomaCANCER INVESTIGATION
2021Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization CURRENT ONCOLOGY
2021Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical ResectionHEPATOLOGY
2021Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy GUT AND LIVER
2021Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovirJOURNAL OF VIRAL HEPATITIS
2021Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 yearsJOURNAL OF DIABETES AND ITS COMPLICATIONS
2020A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapyJOURNAL OF VIRAL HEPATITIS
2020Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion JOURNAL OF HEPATOCELLULAR CARCINOMA
2020MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic MalignancyAMERICAN JOURNAL OF ROENTGENOLOGY
2020Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemiaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyGUT
2020Reply to: "Response to A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma"JOURNAL OF HEPATOLOGY
2020Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver diseaseLIVER INTERNATIONAL
2020Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals CANCERS
2020Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis BDIGESTIVE AND LIVER DISEASE
2020Reply to: "Liver stiffness: A novel predictor of postoperative complications in patients with hepatocellular carcinoma"JOURNAL OF HEPATOLOGY
2020A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinomaJOURNAL OF HEPATOLOGY
2020Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovirJOURNAL OF VIRAL HEPATITIS
2020Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic AttackCEREBROVASCULAR DISEASES
2020Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaJOURNAL OF VIRAL HEPATITIS
2020Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issueALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation CANCERS
2020An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremiaLIVER INTERNATIONAL
2020Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phaseALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapyJOURNAL OF HEPATOLOGY
2020Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2020Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis BGASTROENTEROLOGY
2020Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial RadioembolizationEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B JOURNAL OF KOREAN MEDICAL SCIENCE
2020Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients With Chronic Obstructive Pulmonary Disease INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2020Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskAMERICAN JOURNAL OF GASTROENTEROLOGY
2020Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis CEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea CLINICAL AND MOLECULAR HEPATOLOGY
2020Hepatocellular Carcinoma Risk Steadily Persists Over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter StudyCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
2020Sarcopenia: An Emerging Risk Factor for Non-Alcoholic Fatty Liver DiseaseHEPATOLOGY INTERNATIONAL
2020An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarateJOURNAL OF VIRAL HEPATITIS
2020Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral TherapyCLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Browse

Links